Endostatin's Role in Bone Resorption
Author Information
Author(s): Sipola Annina, Nelo Katri, Hautala Timo, Ilvesaro Joanna, Tuukkanen Juha
Primary Institution: University of Oulu, Finland
Hypothesis
Endostatin may control osteoclastogenesis and osteoclastic bone resorption in vitro.
Conclusion
Endostatin can suppress VEGF-A induced osteoclastic bone resorption to the basal level and inhibit osteoclastogenesis.
Supporting Evidence
- Endostatin inhibited the VEGF-A stimulated osteoclastic bone resorption.
- Endostatin alone had no effect on the basal resorption level.
- Endostatin could inhibit osteoclast differentiation in vitro independent of VEGF-A.
Takeaway
Endostatin helps keep bones healthy by stopping certain cells from breaking them down too much, especially when another signal tries to make them work harder.
Methodology
Rat pit formation assay and osteoclast differentiation assay were used to examine the effects of endostatin and VEGF-A on bone resorption and osteoclast differentiation.
Limitations
The regulatory effect of endostatin is not critical since it does not modify the basal bone resorption.
Participant Demographics
Rat pups and mouse bone marrow cells were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website